Asthma and COVID-19: What do we know now

Clin Med Insights Circ Respir Pulm Med. 2020 Oct 23;14:1179548420966242. doi: 10.1177/1179548420966242. eCollection 2020.

Abstract

The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).

Keywords: COVID-19; asthma; biologics; corticosteroids; respiratory; treatment.

Publication types

  • Review